Abstract
Screening of a marine derived crude natural product extract library, followed by bioactivity guided fractionation, has led to isolation and structural elucidation of 10 natural products as hits active against Mycobacterium tuberculosis (Mtb). Among them, three (3, 4 and 5) were identified for the first time and the remaining 7 compounds (1, 2, 6, 7, 8, 9 and 10) were previously reported, but now assigned with anti-mycobacterial activity. Among identified hits, the oligo cyclic depsipeptide discodermin B (7) exhibited the highest potency with an MIC90 value of 0.5 µM. The polysufide alkaloid lissoclinotoxin F (1) displayed a good balance of anti Mtb potency (MIC90 = 2.6 µM) and selectivity (SI = 19 in HEK293 cells). Lissoclinotoxin F (1) was found to be active against intracellular Mtb as well as non-replicating forms of Mtb, with higher activity against Mtb compared to other gram-negative and gram-positive bacteria. Consequently, lissoclinotoxin F (1) could be used as a lead compound for development of new TB drugs. Details regarding screening techniques, structural elucidation and preliminary structural activity relationships (SAR) of the isolated hits are discussed.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
WHO Global TB Report. WHO Global TB Report 2014. Geneva:WHO; 2014.
Clardy J, Fischbach MA, Currie CR. The natural history of antibiotics. Curr Biol. 2009;19:R437–R441.
Mohr KI. History of antibiotics research. Curr Top Microbiol Immunol. 2016;398:237–72.
Nothias LF, Knight R, Dorrestein PC. Antibiotic discovery is a walk in the park. PNAS. 2016;113:14477–9.
Boucher HW, et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 2009;48:1–12.
Wright GD. Opportunities for natural products in 21st century antibiotic discovery. Nat Prod Rep. 2017;34:694–701.
McSorley FR, Johnson JW, Wright GD. Natural products in antibiotic discovery. In: Fong I, Shlaes D, Drlica K, editors. Antimicrobial resistance in the 21st century. 2nd ed. Cham: Springer; 2018. p. 533–62.
Quan D, Nagalingam G, Payne R, Triccas JA. New tuberculosis drug leads from naturally occurring compounds. Int J Infect Dis. 2017;56:212–20.
Zhang S, Kavianinia I, Brimble MA. Naturally occurring antitubercular cyclic peptides. Tetrahedron Lett. 2019;60:151339.
Moloney MG. Natural products as a source for novel antibiotics. Trends Pharmacol Sci. 2016;37:689–701.
Williams DE, Andersen RJ. Biologically active marine natural products and their molecular targets discovered using a chemical genetics approach. Nat Prod Rep. 2020;37:617–33.
Fusetani N, Yasumuro K, Matsunaga S, Hirota H. Haliclamines A and B, cytotoxic macrocyclic alkaloids from a sponge of the genus Haliclona. Tetrahedron Lett. 1989;30:6891–4.
Matsunaga S, Fusetani N, Konosu S. Bioactive marine metabolites VII. Structures of discodermins B, C, and D, antimicrobial peptides from the marine sponge discodermia kiiensis. Tetrahedron Lett. 1985;26:855–6.
Fattorusso E, Minale L, Sodano G. Aeroplysinin-1, an antibacterial bromo-compound from the sponge Verongia aerophoba. J. Chem. Soc. Perkin Trans. 1. 1972;1:16–8.
Nakamura H, Wu H, Ohizumi Y, Hirata Y. Agelasine-A, -B, -C and -D, novel bicyclic diterpenoids with a 9-methyladeninium unit possessing inhibitory effects on Na, K-Atpase from the Okinawa sea sponge Agelas sp.1. Tetrahedron Lett. 1984;25:2989–92.
Borders DB, Morton GO, Wetzel ER. Structure, of a novel bromine compound isolated from a sponge. Tetrahedron Lett. 1974;31:2709–12.
Richter A, Strauch A, Chao J, Ko M, Av-Gay Y. Screening of preselected libraries targeting mycobacterium abscessus for drug discovery. Antimicrob. Agents Chemother. 2018. https://doi.org/10.1128/AAC.00828-18.
Zheng X, Av-Gay Y. System for efficacy and cytotoxicity screening of inhibitors targeting intracellular mycobacterium tuberculosis. J Vis Exp. 2017. https://doi.org/10.3791/55273.
Khalil ZG, Hill TA, De Leon Rodriguez LM, Lohman RJ, Hoang HN, Reiling N, et al. Structure-activity relationships of wollamide cyclic hexapeptides with activity against drug-resistant and intracellular mycobacterium tuberculosis. Antimicrob. Agents Chemother. 2019. https://doi.org/10.1128/AAC.01773-18.
Davis RA, Sandoval IT, Concepcion GP, Moreira Da Rocha R, Ireland CM. Lissoclinotoxins E and F, novel cytotoxic alkaloids from a Philippine didemnid ascidian. Tetrahedron. 2003;59:2855–9.
Liu H, Fujiwara T, Nishikawa T, Mishima Y, Nagai H, Shida T, et al. Lissoclibadins 1-3, three new polysulfur alkaloids, from the ascidian Lissoclinum cf. badium. Tetrahedron. 2005;61:8611–5.
Charan RD, Garson MJ, Brereton IM, Willis AC, Hooper JNA. Haliclonacyclamines A and B, cytotoxic alkaloids from the tropical marine sponge Haliclona sp. Tetrahedron 1996;52:9111–20.
Arai M, Ishida S, Setiawan A, Kobayashi M. Haliclonacyclamines, tetracyclic alkylpiperidine alkaloids, as anti-dormant mycobacterial substances from a marine sponge of Haliclona sp. Chem Pharm Bull. 2009;57:1136–8.
Matsunaga S, Miyata Y, Van Soest RWM, Fusetani N. Tetradehydrohalicyclamine A and 22-hydroxyhalicyclamine A, new cytotoxic bis-piperidine alkaloids from a marine sponge Amphimedon sp. J Nat Prod 2004;67:1758–60.
Hestvik ALK, Hmama Z, Av-Gay Y. Mycobacterial manipulation of the host cell. FEMS Microbiol Rev. 2005;29:1041–50.
Rankine-Wilson LI, Shapira T, Emani CS, Av-Gay Y. From infection niche to therapeutic target: the intracellular lifestyle of Mycobacterium tuberculosis. Microbiology. 2021;167. https://doi.org/10.1099/MIC.0.001041
Schaaf K, Hayley V, Speer A, Wolschendorf F, Niederweis M, Kutsch O, et al. A Macrophage infection model to predict drug efficacy against Mycobacterium tuberculosis. Assay Drug Dev. Technol. 2016. https://doi.org/10.1089/adt.2016.717.
Inderlied CB. Antimycobacterial susceptibility testing: Present practices and future trends. Eur J Clin Microbiol Infect Dis 1994;13:980–93.
Nakazawa T, Xu J, Nishikawa T, Oda T, Fujita A, Ukai K, et al. Lissoclibadins 4-7, polysulfur aromatic alkaloids from the Indonesian ascidian Lissoclinum cf. badium. J Nat Prod. 2007;70:439–42.
Wang W, Takahashi O, Oda T, Nakazawa T, Ukai K, Mangindaan REP, et al. Lissoclibadins 8-14, polysulfur dopamine-derived alkaloids from the colonial ascidian Lissoclinum cf. badium. Tetrahedron. 2009;65:9598–603.
Searle PA, Molinski TF. ChemInform abstract: five new alkaloids from the tropical ascidian, Lissoclinum Sp. - Lissoclinotoxin A is chiral. ChemInform. 2010. https://doi.org/10.1002/chin.199520199.
Liu H, Pratasik SB, Nishikawa T, Shida T, Tachibana K, Fujiwara T, et al. Lissoclibadin 1, a novel trimeric sulfur-bridged dopamine derivative, from the tropical ascidian Lissoclinum cf. badium. Tetrahedron Lett. 2004;45:7015–7.
Oda T, Kamoshita K, Maruyama S, Masuda K, Nishimoto M, Xu J, et al. Cytotoxicity of lissoclibadins and lissoclinotoxins, isolated from a tropical ascidian Lissoclinum cf. badium, against human solid-tumor-derived cell lines. Biol Pharm Bull. 2007;30:385–7.
Zulfiqar B, Jones AJ, Sykes ML, Shelper TB, Davis RA, Avery VM. Screening a natural product-based library against kinetoplastid parasites. Molecules. 2017;22:1715.
Tatsuta T, Hosono M, Rotinsulu H, Wewengkang DS, Sumilat DA, Namikoshi M, et al. Lissoclibadin 1, a polysulfur aromatic alkaloid from the Indonesian ascidian Lissoclinum cf. badium, induces caspase-dependent apoptosis in human colon cancer cells and suppresses tumor growth in nude mice. J Nat Prod 2017;80:499–502.
Jaspars M, Pasupathy V, Crews P. A tetracyclic diamine alkaloid, halicyclamine A, from the marine sponge Haliclona sp. J Org Chem. 1994;59:3253–5.
Arai M, Sobou M, Vilchéze C, Baughn A, Hashizume H, Pruksakorn P, et al. Halicyclamine A, a marine spongean alkaloid as a lead for anti-tuberculosis agent. Bioorg Med Chem. 2008;16:6732–6.
Ryu G, Matsunaga S, Fusetani N, Discodermins F-H. cytotoxic and antimicrobial tetradecapeptides from the marine sponge Discodermia kiiensis: structure revision of discodermins A-D. Tetrahedron. 1994;50:13409–16.
Cardote TAF, Ciulli A. Cyclic and macrocyclic peptides as chemical tools to recognise protein surfaces and probe protein-protein interactions. ChemMedChem. 2016;11:787–94.
Qian Z, Dougherty PG, Pei D. Targeting intracellular protein–protein interactions with cell-permeable cyclic peptides. Curr Opin Chem Biol. 2017;38:80–86.
Asfaw H, Laqua K, Walkowska AM, Cunningham F, Martinez-Martinez MS, Cuevas-Zurita JC, et al. Design, synthesis and structure-activity relationship study of wollamide B; a new potential anti TB agent. PLoS ONE. 2017. https://doi.org/10.1371/journal.pone.0176088.
Asfaw H, Wetzlar T, Martinez-Martinez MS, Imming P. An efficient synthetic route for preparation of antimycobacterial wollamides and evaluation of their in vitro and in vivo efficacy. Bioorg Med Chem Lett. 2018;28:2899–2905.
García-Vilas JA, Martínez-Poveda B, Quesada AR, Medina MÁ. Aeroplysinin-1, a sponge-derived multi-targeted bioactive marine drug. Mar Drugs. 2016. https://doi.org/10.3390/md14010001.
Acknowledgements
Funding for this work was provided by the Canadian Institute of Health Research PJT-148646 and PJT-152931.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Sahile, H.A., Williams, D.E., de Voogd, N.J. et al. Screening of diverse marine invertebrate extracts identified Lissoclinotoxin F, Discodermin B, and other anti-Mycobacterium tuberculosis active compounds. J Antibiot 75, 213–225 (2022). https://doi.org/10.1038/s41429-022-00507-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41429-022-00507-9